JP2018510639A5 - - Google Patents

Download PDF

Info

Publication number
JP2018510639A5
JP2018510639A5 JP2017549766A JP2017549766A JP2018510639A5 JP 2018510639 A5 JP2018510639 A5 JP 2018510639A5 JP 2017549766 A JP2017549766 A JP 2017549766A JP 2017549766 A JP2017549766 A JP 2017549766A JP 2018510639 A5 JP2018510639 A5 JP 2018510639A5
Authority
JP
Japan
Prior art keywords
car
item
polypeptide
nucleic acid
multimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549766A
Other languages
English (en)
Japanese (ja)
Other versions
JP6675417B2 (ja
JP2018510639A (ja
Filing date
Publication date
Priority claimed from GBGB1504840.8A external-priority patent/GB201504840D0/en
Application filed filed Critical
Publication of JP2018510639A publication Critical patent/JP2018510639A/ja
Publication of JP2018510639A5 publication Critical patent/JP2018510639A5/ja
Application granted granted Critical
Publication of JP6675417B2 publication Critical patent/JP6675417B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549766A 2015-03-23 2016-03-22 キメラ抗原受容体 Expired - Fee Related JP6675417B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1504840.8A GB201504840D0 (en) 2015-03-23 2015-03-23 Chimeric antigen receptor
GB1504840.8 2015-03-23
PCT/GB2016/050795 WO2016151315A1 (en) 2015-03-23 2016-03-22 Chimeric antigen receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020001971A Division JP2020048588A (ja) 2015-03-23 2020-01-09 キメラ抗原受容体

Publications (3)

Publication Number Publication Date
JP2018510639A JP2018510639A (ja) 2018-04-19
JP2018510639A5 true JP2018510639A5 (cg-RX-API-DMAC7.html) 2019-12-05
JP6675417B2 JP6675417B2 (ja) 2020-04-01

Family

ID=53052211

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017549766A Expired - Fee Related JP6675417B2 (ja) 2015-03-23 2016-03-22 キメラ抗原受容体
JP2020001971A Withdrawn JP2020048588A (ja) 2015-03-23 2020-01-09 キメラ抗原受容体
JP2022201192A Withdrawn JP2023021396A (ja) 2015-03-23 2022-12-16 キメラ抗原受容体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020001971A Withdrawn JP2020048588A (ja) 2015-03-23 2020-01-09 キメラ抗原受容体
JP2022201192A Withdrawn JP2023021396A (ja) 2015-03-23 2022-12-16 キメラ抗原受容体

Country Status (21)

Country Link
US (1) US11058722B2 (cg-RX-API-DMAC7.html)
EP (1) EP3274366B8 (cg-RX-API-DMAC7.html)
JP (3) JP6675417B2 (cg-RX-API-DMAC7.html)
KR (1) KR102174280B1 (cg-RX-API-DMAC7.html)
CN (1) CN107406518B (cg-RX-API-DMAC7.html)
AU (1) AU2016238583B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017018252A2 (cg-RX-API-DMAC7.html)
CA (1) CA2978852C (cg-RX-API-DMAC7.html)
CL (1) CL2017002413A1 (cg-RX-API-DMAC7.html)
DK (1) DK3274366T3 (cg-RX-API-DMAC7.html)
ES (1) ES2773527T3 (cg-RX-API-DMAC7.html)
GB (1) GB201504840D0 (cg-RX-API-DMAC7.html)
HU (1) HUE047929T2 (cg-RX-API-DMAC7.html)
IL (1) IL254254B (cg-RX-API-DMAC7.html)
MX (1) MX371384B (cg-RX-API-DMAC7.html)
PL (1) PL3274366T3 (cg-RX-API-DMAC7.html)
PT (1) PT3274366T (cg-RX-API-DMAC7.html)
RU (1) RU2752880C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201706940QA (cg-RX-API-DMAC7.html)
WO (1) WO2016151315A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201705682B (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201505858VA (en) 2013-01-28 2015-09-29 St Jude Childrens Res Hospital A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
US11982672B2 (en) 2014-03-05 2024-05-14 Autolus Limited Methods
US11385233B2 (en) 2015-03-05 2022-07-12 Autolus Limited Methods of depleting malignant T-cells
GB201403972D0 (en) 2014-03-06 2014-04-23 Ucl Business Plc Chimeric antigen receptor
GB201405845D0 (en) 2014-04-01 2014-05-14 Ucl Business Plc Signalling system
EP3805371A1 (en) 2014-05-15 2021-04-14 National University of Singapore Modified natural killer cells and uses thereof
GB201415347D0 (en) 2014-08-29 2014-10-15 Ucl Business Plc Signalling system
GB201501936D0 (en) * 2015-02-05 2015-03-25 Ucl Business Plc Signalling system
EP3770168A1 (en) 2015-05-18 2021-01-27 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
WO2017180587A2 (en) 2016-04-11 2017-10-19 Obsidian Therapeutics, Inc. Regulated biocircuit systems
GB201610512D0 (en) 2016-06-16 2016-08-03 Autolus Ltd Chimeric antigen receptor
WO2018026953A1 (en) 2016-08-02 2018-02-08 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
BR112019007100A2 (pt) 2016-10-07 2019-06-25 Tcr2 Therapeutics Inc composições e métodos para reprogramação de receptores de célula t com o uso de proteínas de fusão
CN110177803A (zh) 2016-11-22 2019-08-27 T细胞受体治疗公司 用于使用融合蛋白进行tcr重新编程的组合物和方法
MX2019011570A (es) 2017-03-27 2019-11-18 Nat Univ Singapore Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
CN117363636A (zh) 2017-03-27 2024-01-09 新加坡国立大学 一种编码嵌合受体的多核苷酸
US20200181225A1 (en) * 2017-03-29 2020-06-11 Sunnybrook Research Institute Engineered t-cell modulating molecules and methods of using same
BR112019023608A2 (pt) 2017-05-12 2020-05-26 Crispr Therapeutics Ag Materiais e métodos para células manipuladas e seus usos em imuno-oncologia
US11166985B2 (en) 2017-05-12 2021-11-09 Crispr Therapeutics Ag Materials and methods for engineering cells and uses thereof in immuno-oncology
WO2019025800A1 (en) * 2017-08-02 2019-02-07 Autolus Limited CELLS EXPRESSING A CHIMERIC ANTIGENIC RECEPTOR OR A MANIPULATED TCR AND COMPRISING A SELECTIVELY EXPRESSED SELECTIVE NUCLEOTIDE SEQUENCE
CN111295392A (zh) 2017-11-01 2020-06-16 豪夫迈·罗氏有限公司 Compbody–多价靶结合物
GB201801831D0 (en) * 2018-02-05 2018-03-21 Autolus Ltd Chimeric receptor
JP7360174B2 (ja) 2018-02-09 2023-10-12 ナショナル ユニヴァーシティー オブ シンガポール ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用
US12441787B2 (en) 2018-04-02 2025-10-14 National University Of Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
US20200063100A1 (en) 2018-05-11 2020-02-27 Crispr Therapeutics Ag Methods and compositions for treating cancer
GB201807870D0 (en) 2018-05-15 2018-06-27 Autolus Ltd A CD79-specific chimeric antigen receptor
WO2019220109A1 (en) 2018-05-15 2019-11-21 Autolus Limited Chimeric antigen receptor
CN112930186A (zh) * 2018-08-16 2021-06-08 纪念斯隆-凯特琳癌症中心 基于亮氨酸拉链的组合物和使用方法
WO2020044239A1 (en) 2018-08-29 2020-03-05 National University Of Singapore A method to specifically stimulate survival and expansion of genetically-modified immune cells
CN109265550B (zh) * 2018-09-25 2020-09-15 华东师范大学 Bcma抗体、嵌合抗原受体和药物
SG11202102781UA (en) 2018-09-27 2021-04-29 Autolus Ltd Chimeric antigen receptor
KR20210072797A (ko) * 2018-10-05 2021-06-17 세인트 안나 킨더크렙스포르슝 키메라 항원 수용체(car) 그룹
JP2022512594A (ja) * 2018-10-05 2022-02-07 ザンクト アンナ キンダークレプスフォルシュング キメラ抗原受容体(car)の群
GB201817822D0 (en) 2018-10-31 2018-12-19 Autolus Ltd Binding domain
CN113226340A (zh) 2018-11-26 2021-08-06 恩卡尔塔公司 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
KR20210132668A (ko) * 2019-02-21 2021-11-04 아르벨 리미티드 인공 면역감시 키메라 항원 수용체(ai-car) 및 이를 발현하는 세포
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
KR20210143246A (ko) 2019-03-21 2021-11-26 리제너론 파아마슈티컬스, 인크. 알레르기 치료용 il-4/il-13 경로 억제제 및 형질 세포 절제의 병용
CA3138633A1 (en) 2019-04-30 2020-11-05 Crispr Therapeutics Ag Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19
AU2020382219A1 (en) 2019-11-13 2022-05-12 Crispr Therapeutics Ag Manufacturing process for making T cells expressing chimeric antigen receptors
GB201919017D0 (en) 2019-12-20 2020-02-05 Autolus Ltd Cell
CN111234033B (zh) * 2020-01-21 2021-05-11 南京北恒生物科技有限公司 多链嵌合抗原受体及其用途
GB202004263D0 (en) 2020-03-24 2020-05-06 Autolus Ltd Antibody conjugate
GB202005216D0 (en) 2020-04-08 2020-05-20 Autolus Ltd Cell
GB202006820D0 (en) 2020-05-07 2020-06-24 Autolus Ltd Cell
GB202017649D0 (en) 2020-11-09 2020-12-23 Autolus Ltd Polypeptide
AU2022227686A1 (en) 2021-02-25 2023-07-27 Lyell Immunopharma, Inc. Ror1 targeting chimeric antigen receptor
WO2022204326A1 (en) * 2021-03-24 2022-09-29 The Regents Of The University Of California Humanized synthetic notch receptors with augmented transactivation domains and uses thereof
GB202115329D0 (en) * 2021-10-25 2021-12-08 Autolus Ltd Chimeric cytokine receptor
WO2024019961A1 (en) * 2022-07-18 2024-01-25 Cargo Therapeutics, Inc. Cd2 recruiting chimeric antigen receptors and fusion proteins
US20250242056A1 (en) 2024-01-26 2025-07-31 Regeneron Pharmaceuticals, Inc. Methods and compositions for using plasma cell depleting agents and/or b cell depleting agents to suppress host anti-aav antibody response and enable aav transduction and re-dosing
WO2025160340A2 (en) 2024-01-26 2025-07-31 Regeneron Pharmaceuticals, Inc. Combination immunosuppression for inhibiting an immune response and enabling immunogen administration and re-administration
WO2025184567A1 (en) 2024-03-01 2025-09-04 Regeneron Pharmaceuticals, Inc. Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody response
WO2026151982A1 (en) 2025-01-10 2026-07-16 Regeneron Pharmaceuticals, Inc. Methods of treating food allergy by administering an il-4r antagonist and a bcma targeting agent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081443B2 (en) 2002-05-21 2006-07-25 Korea Advanced Institutes Of Science And Technology (Kaist) Chimeric comp-ang1 molecule
WO2010102518A1 (zh) * 2009-03-13 2010-09-16 北京表源生物技术有限公司 一种融合蛋白多聚体
KR101156085B1 (ko) * 2010-01-29 2012-06-20 국립암센터 4-1bb리간드(4-1bbl)오중합체 및 이의 용도
US10745467B2 (en) * 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
JP6053688B2 (ja) * 2011-10-07 2016-12-27 国立大学法人三重大学 キメラ抗原受容体
SG10201806573TA (en) * 2012-05-25 2018-09-27 Cellectis Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
AU2013312838B2 (en) 2012-09-04 2018-11-29 Cellectis Multi-chain chimeric antigen receptor and uses thereof
IL305629A (en) * 2013-02-15 2023-11-01 Univ California Chimeric antigen receptor and methods of using it
CN103145849B (zh) 2013-02-18 2014-06-11 冯振卿 嵌合抗原受体及其用途
NZ759969A (en) * 2013-12-20 2022-12-23 Fred Hutchinson Cancer Center Tagged chimeric effector molecules and receptors thereof
CN107074957B (zh) 2014-01-13 2021-05-07 希望之城公司 在Fc间隔物区中具有突变的嵌合抗原受体(CAR)及其使用方法
GB201415347D0 (en) 2014-08-29 2014-10-15 Ucl Business Plc Signalling system
GB201610512D0 (en) 2016-06-16 2016-08-03 Autolus Ltd Chimeric antigen receptor

Similar Documents

Publication Publication Date Title
RU2017132978A (ru) Химерный рецептор антигена
JP2020517287A5 (cg-RX-API-DMAC7.html)
CN112074532B (zh) 结合非天然NKG2D受体的非天然NKG2D配体的修饰的α1-α2结构域
JP2019535262A5 (cg-RX-API-DMAC7.html)
JP2023071729A5 (cg-RX-API-DMAC7.html)
JP6853250B2 (ja) 抗体の挿入可能な可変フラグメント及びnkg2dリガンドの改変されたa1−a2ドメイン、及び非天然のnkg2d受容体に結合する非天然のnkg2dリガンド
JP2020517294A5 (cg-RX-API-DMAC7.html)
JP2019150066A5 (cg-RX-API-DMAC7.html)
JP2018529380A5 (cg-RX-API-DMAC7.html)
JP2020529841A5 (cg-RX-API-DMAC7.html)
JP2019533449A5 (cg-RX-API-DMAC7.html)
CN111094333A (zh) 异源二聚化的Ig结构域
JP2024023228A5 (cg-RX-API-DMAC7.html)
JP2016536322A5 (cg-RX-API-DMAC7.html)
JP2014158485A5 (cg-RX-API-DMAC7.html)
JP2017529067A5 (cg-RX-API-DMAC7.html)
JP2018518459A5 (cg-RX-API-DMAC7.html)
JP2018523484A5 (cg-RX-API-DMAC7.html)
CA2497496A1 (en) In vitro peptide expression library
CA3140064A1 (en) Lockr-mediated recruitment of car t cells
JP2018528786A5 (cg-RX-API-DMAC7.html)
JP2017534296A5 (cg-RX-API-DMAC7.html)
IL292387B2 (en) Chimeric polypeptide for regulating immune cells
Zhu et al. COMBODY: one‐domain antibody multimer with improved avidity
JP2014529590A5 (cg-RX-API-DMAC7.html)